Brian Wahlberg
About Brian Wahlberg
Brian Wahlberg is a Research Associate at the Broad Institute of MIT and Harvard, specializing in genetic perturbation and cancer research. He contributes to the Dependency Map project and has a background in Biomedical Engineering from the University of Miami.
Work at Broad Institute
Brian Wahlberg has been employed at the Broad Institute of MIT and Harvard since 2019, serving as a Research Associate in the Genetic Perturbation Platform. His role involves significant contributions to the Dependency Map project, which is a critical resource aimed at elucidating cancer gene dependencies. As a member of the Achilles team, he focuses on the utilization of genome-wide sgRNA libraries to advance cancer research. His work supports the broader mission of the Broad Institute in understanding the genetic underpinnings of diseases.
Education and Expertise
Brian Wahlberg earned a Bachelor's degree in Biomedical/Medical Engineering from the University of Miami, where he studied from 2015 to 2019. His education provided him with a strong foundation in the principles of biomedical engineering, which he applies in his current research. He also completed his secondary education at Xaverian Brothers High School from 2011 to 2015. Brian specializes in performing CRISPR knockout screens, a technique essential for identifying gene dependencies in cancer cell lines.
Background
Brian Wahlberg's professional background includes an internship at C4 Therapeutics, Inc., where he worked as a Biophysics/Biochemistry Intern from 2017 to 2018. This experience in a biotechnology setting contributed to his understanding of biophysical and biochemical principles relevant to cancer research. His transition from intern to a research associate at the Broad Institute reflects his commitment to advancing the field of biomedical research.
Career Aspirations
Brian Wahlberg aims to transition into a management or financial role within the biotechnology sector after obtaining an MBA. This goal indicates his interest in combining his scientific expertise with business acumen to contribute to the biotechnology industry in a leadership capacity. His current experience at the Broad Institute positions him well for future opportunities in management.